In last trading session, Medicus Pharma Ltd (NASDAQ:MDCX) saw 0.31 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $6.73 trading at $0.78 or 13.11% at ring of the bell on the day assigns it a market valuation of $79.55M. That closing price of MDCX’s stock is at a discount of -3.71% from its 52-week high price of $6.98 and is indicating a premium of 73.25% from its 52-week low price of $1.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 84.25K if we extend that period to 3-months.

Medicus Pharma Ltd (NASDAQ:MDCX) trade information

Upright in the green during last session for gaining 13.11%, in the last five days MDCX remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $6.73 price level, adding 3.86% to its value on the day. Medicus Pharma Ltd’s shares saw a change of 176.95% in year-to-date performance and have moved 46.62% in past 5-day. Medicus Pharma Ltd (NASDAQ:MDCX) showed a performance of 74.81% in past 30-days. Number of shares sold short was 47094.0 shares which calculate 0.78 days to cover the short interests.

In 2025, company’s earnings growth rate is likely to be around 11.21% while estimates for its earnings growth in next 5 years are of 5.68%.

Medicus Pharma Ltd (NASDAQ:MDCX)’s Major holders

Insiders are in possession of 51.37% of company’s total shares while institution are holding 22.53 percent of that, with stock having share float percentage of 46.32%. Investors also watch the number of corporate investors in a company very closely, which is 22.53% institutions for Medicus Pharma Ltd that are currently holding shares of the company.